Metabolism, Diabetes, and Cancer
Metabolism, Diabetes, and Cancer is a research topic within Molecular Biology. Science Explorer counts 45k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
- AMP-activated Protein Kinase
- Metformin
- Glucose
- Insulin Signaling
- Cancer Risk
- Cellular Energy
- Mitochondrial Homeostasis
- Glycogen Metabolism
- Regulation of Gene Expression
- Tumor Suppression
- Research works
- 45k fractional, since 1950
- In the world top 10%
- 4.4k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -1% the tick is no change
- Largest producer
China
32% of the 10 largest, 2022-now
Which countries lead Metabolism, Diabetes, and Cancer research?
By volume, China and the United States publish the most (1.5k and 1.4k works in 2022-now).
By volume, 2022-now
- 1
China 1.5k works
- 2
United States 1.4k works
- 3
India 407 works
- 4
Japan 281 works
- 5
South Korea 247 works
- 6
Italy 235 works
- 7
United Kingdom 220 works
- 8
Germany 192 works
- 9
Canada 138 works
- 10
Iran 137 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Metabolism, Diabetes, and Cancer research?
By volume in 2022-now, Harvard University publishes the most Metabolism, Diabetes, and Cancer research, followed by Shanghai Jiao Tong University and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022-now
- 1
Harvard University
United States 59 works
- 2
Shanghai Jiao Tong University
China 36 works
- 3
Chinese Academy of Medical Sciences & Peking Union Medical College
China 30 works
- 4
Peking University
China 29 works
- 5
Sichuan University
China 28 works
- 6
Nanjing Medical University
China 28 works
- 7
Sun Yat-sen University
China 28 works
- 8
Capital Medical University
China 27 works
- 9
University of North Carolina at Chapel Hill
United States 26 works
- 10
Chinese Academy of Sciences
China 25 works
Who are the leading researchers in Metabolism, Diabetes, and Cancer?
The most-cited researchers publishing on Metabolism, Diabetes, and Cancer include David Moher, Eric S. Lander and Rob Knight.
- 1
David Moher
Canada 898k citations
- 2
Eric S. Lander
United States 524k citations
- 3
Rob Knight
United States 468k citations
- 4
George Davey Smith
United Kingdom 435k citations
- 5
Ali H. Mokdad
United States 429k citations
- 6
Walter Churchill Willett
United States 411k citations
- 7
Mark J. Daly
United States 403k citations
- 8
Stacey L. Gabriel
United States 402k citations
- 9
Julian P. T. Higgins
United Kingdom 390k citations
- 10
Guido Kroemer
France 386k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Metabolism, Diabetes, and Cancer research done?
The largest centres of Metabolism, Diabetes, and Cancer research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis and Düsseldorf.
Largest cities, 2022-now
Where it is the local speciality
- IndianapolisUS · 25.3 works6.0×
- DüsseldorfDE · 20.1 works5.7×
Location quotient: how much more of its research is in Metabolism, Diabetes, and Cancer than the world average.
Where is the best place to study Metabolism, Diabetes, and Cancer?
Among universities, judged by research, Harvard University, Case Western Reserve University and Sichuan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Metabolism, Diabetes, and Cancer, country by countryIs Metabolism, Diabetes, and Cancer research growing?
Output in 2022-2025 was 1% lower than in 2018-2021, peaking in 2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Metabolism, Diabetes, and Cancer as a percentage of every work published that year, 0.028% in 2024.
Fractional works of Metabolism, Diabetes, and Cancer over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Metabolism, Diabetes, and Cancer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.